This is a Validated Antibody Database (VAD) review about Chinese ha.. Ezr, based on 17 published articles (read how Labome selects the articles), using Ezr antibody in all methods. It is aimed to help Labome visitors find the most suited Ezr antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Ezr synonym: ezrin

Invitrogen
mouse monoclonal (3C12)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2a
In order to assess the expression and the prognostic significance of CD133 and ezrin mRNA and protein in primary colorectal cancer cases, Invitrogen Ezr antibody (lab vision, 3c12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2a). IUBMB Life (2017) ncbi
mouse monoclonal (3C12)
  • western blot; human; loading ...; fig 1b
In order to explore how C-kinase potentiated protein phosphatase-1 inhibitor of 17 kDa drives Ras activity and tumorigenesis, Invitrogen Ezr antibody (NeoMarkers, 3C12) was used in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
mouse monoclonal (3C12)
  • immunohistochemistry; rat; 1:400; loading ...; fig 7d
In order to find that adenosine A2B receptors on the luminal membranes of Capan-1 cells are the functional adenosine receptors and Cl(-) channels important for anion secretion, Invitrogen Ezr antibody (Lab Vision, MS-661) was used in immunohistochemistry on rat samples at 1:400 (fig 7d). Pflugers Arch (2016) ncbi
mouse monoclonal (3C12)
  • immunohistochemistry - paraffin section; mouse; 1:200
In order to investigate the role of transcription factors SOX4 and SOX9 during the development of bile ducts, Invitrogen Ezr antibody (Neomarkers, MS661P1) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Dev Biol (2015) ncbi
mouse monoclonal (3C12)
  • immunohistochemistry; human; 1:1000
In order to study the possible role of podoplanin and ezrin in the invasion of the ameloblastomas, Invitrogen Ezr antibody (LabVision Co., MS-661P) was used in immunohistochemistry on human samples at 1:1000. Eur J Histochem (2015) ncbi
mouse monoclonal (3C12)
  • western blot; mouse
Invitrogen Ezr antibody (Thermo Fisher Scientific, 3C12) was used in western blot on mouse samples . Mol Cancer Res (2015) ncbi
mouse monoclonal (3C12)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to assess the prognostic value of an immunohistochemistry-based three-protein signature model in patients with esophageal squamous cell carcinoma, Invitrogen Ezr antibody (Neomarkers, MS-661) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (3C12)
  • immunohistochemistry - paraffin section; human
In order to explore the activity and safety of front-line dose-dense chemotherapy in high-grade soft tissue sarcoma patients and test ezrin as prognostic factor, Invitrogen Ezr antibody (NeoMarkers, 3C12) was used in immunohistochemistry - paraffin section on human samples . Sarcoma (2011) ncbi
mouse monoclonal (3C12)
  • western blot; human; fig 1
In order to identify intercellular adhesion molecule-1 as a new coreceptor for c-Met, Invitrogen Ezr antibody (NeoMarkers, 3C12) was used in western blot on human samples (fig 1). Mol Biol Cell (2011) ncbi
mouse monoclonal (3C12)
  • immunohistochemistry - paraffin section; human; 1:100; fig 3
  • western blot; human; 1:2000; fig 5
In order to examine the raft and cytoskeletal proteins from intrauterine growth restriction and preeclampsia, Invitrogen Ezr antibody (Zymed, clone 3C12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3) and in western blot on human samples at 1:2000 (fig 5). J Membr Biol (2011) ncbi
mouse monoclonal (3C12)
  • western blot; human; fig 2
In order to explore how cell density affects the morphological and physiological properties of differentiated Caco-2 cells, Invitrogen Ezr antibody (Zymed, 3C12) was used in western blot on human samples (fig 2). J Cell Physiol (2011) ncbi
mouse monoclonal (3C12)
  • immunohistochemistry; human; fig 7
In order to determine the origin of urinary podocalyxin, Invitrogen Ezr antibody (Zymed, 3C12) was used in immunohistochemistry on human samples (fig 7). Hum Pathol (2010) ncbi
mouse monoclonal (3C12)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to identify a prognostic immunohistochemical signature indicative of risk of early metastasis in node-negative breast carcinomas and use this information to develop targeted therapies, Invitrogen Ezr antibody (Neomarkers, 3C12) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Int J Oncol (2010) ncbi
mouse monoclonal (3C12)
  • immunohistochemistry; human; tbl 3
In order to identify prognostic immunohistochemical molecular signatures indicative of disease outcome in triple-negative breast cancers, Invitrogen Ezr antibody (Neomarkers, 3C12) was used in immunohistochemistry on human samples (tbl 3). Int J Oncol (2009) ncbi
mouse monoclonal (3C12)
  • immunohistochemistry - paraffin section; human; tbl 1
  • immunohistochemistry; human
In order to identify prognostic signatures in breast carcinomas using quantitative immunocytochemical assays, Invitrogen Ezr antibody (Neomarkers, 3C12) was used in immunohistochemistry - paraffin section on human samples (tbl 1) and in immunohistochemistry on human samples . Int J Cancer (2009) ncbi
mouse monoclonal (3C12)
  • immunohistochemistry - paraffin section; human; 1:100
In order to determine the localization and function of Duox1/Duoxa1 homologues, Invitrogen Ezr antibody (Invitrogen, 3C12) was used in immunohistochemistry - paraffin section on human samples at 1:100. FASEB J (2009) ncbi
mouse monoclonal (3C12)
  • western blot; human; fig 2
In order to assess the effect of granzyme M on components of the cytoskeleton, Invitrogen Ezr antibody (Zymed, 3C12) was used in western blot on human samples (fig 2). J Immunol (2008) ncbi
Articles Reviewed
  1. Fathi A, Mosaad H, Hussein S, Roshdy M, Ismail E. Prognostic significance of CD133 and ezrin expression in colorectal carcinoma. IUBMB Life. 2017;69:328-340 pubmed publisher
  2. Riecken L, Zoch A, Wiehl U, Reichert S, Scholl I, Cui Y, et al. CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins. Oncotarget. 2016;7:78242-78254 pubmed publisher
  3. Hayashi M, Inagaki A, Novak I, Matsuda H. The adenosine A2B receptor is involved in anion secretion in human pancreatic duct Capan-1 epithelial cells. Pflugers Arch. 2016;468:1171-81 pubmed publisher
  4. Poncy A, Antoniou A, Cordi S, Pierreux C, Jacquemin P, Lemaigre F. Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts. Dev Biol. 2015;404:136-48 pubmed publisher
  5. Costa Y, Tjioe K, Nonogaki S, Soares F, Lauris J, Oliveira D. Are podoplanin and ezrin involved in the invasion process of the ameloblastomas?. Eur J Histochem. 2015;59:2451 pubmed publisher
  6. Hartmann M, Parra L, Ruschel A, Böhme S, Li Y, Morrison H, et al. Tumor Suppressor NF2 Blocks Cellular Migration by Inhibiting Ectodomain Cleavage of CD44. Mol Cancer Res. 2015;13:879-90 pubmed publisher
  7. Cao H, Zhang S, SHEN J, Wu Z, Wu J, Wang S, et al. A three-protein signature and clinical outcome in esophageal squamous cell carcinoma. Oncotarget. 2015;6:5435-48 pubmed
  8. Almeida G, Castro G, Snitcovsky I, Siqueira S, Akaishi E, Camargo O, et al. Sequential dose-dense Doxorubicin and Ifosfamide in advanced soft-tissue sarcoma patients in an out-patient-basis schedule. Sarcoma. 2011;2011:984340 pubmed publisher
  9. Olaku V, Matzke A, Mitchell C, Hasenauer S, Sakkaravarthi A, Pace G, et al. c-Met recruits ICAM-1 as a coreceptor to compensate for the loss of CD44 in Cd44 null mice. Mol Biol Cell. 2011;22:2777-86 pubmed publisher
  10. Riquelme G, Vallejos C, de Gregorio N, Morales B, Godoy V, Berrios M, et al. Lipid rafts and cytoskeletal proteins in placental microvilli membranes from preeclamptic and IUGR pregnancies. J Membr Biol. 2011;241:127-40 pubmed publisher
  11. Natoli M, Leoni B, D Agnano I, D Onofrio M, Brandi R, Arisi I, et al. Cell growing density affects the structural and functional properties of Caco-2 differentiated monolayer. J Cell Physiol. 2011;226:1531-43 pubmed publisher
  12. Hara M, Yanagihara T, Hirayama Y, Ogasawara S, Kurosawa H, Sekine S, et al. Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli. Hum Pathol. 2010;41:1265-75 pubmed publisher
  13. Giusiano S, Secq V, Carcopino X, Carpentier S, Andrac L, Lavaut M, et al. Immunohistochemical profiling of node negative breast carcinomas allows prediction of metastatic risk. Int J Oncol. 2010;36:889-98 pubmed
  14. Charpin C, Giusiano S, Secq V, Carpentier S, Andrac L, Lavaut M, et al. Quantitative immunocytochemical profile to predict early outcome of disease in triple-negative breast carcinomas. Int J Oncol. 2009;34:983-93 pubmed
  15. Charpin C, Secq V, Giusiano S, Carpentier S, Andrac L, Lavaut M, et al. A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays. Int J Cancer. 2009;124:2124-34 pubmed publisher
  16. Morand S, Ueyama T, Tsujibe S, Saito N, Korzeniowska A, Leto T. Duox maturation factors form cell surface complexes with Duox affecting the specificity of reactive oxygen species generation. FASEB J. 2009;23:1205-18 pubmed publisher
  17. Bovenschen N, de Koning P, Quadir R, Broekhuizen R, Damen J, Froelich C, et al. NK cell protease granzyme M targets alpha-tubulin and disorganizes the microtubule network. J Immunol. 2008;180:8184-91 pubmed